
June 2023
Ampath | ampath.co.za
Introduction
Ampath now offers the Oncomine™ Precision Assay Liquid Biopsy (LBPA), a cutting-edge test for comprehensive analysis of solid tumour malignancies using cell-free DNA from blood samples.
Platform:
- Performed on the Ion Torrent Genexus system
- Detects the same variants and fusions as the tissue-based OPANGS (Oncomine™ Precision Assay – FFPE)
This test complements, but does not replace, the existing EGFR T790M liquid biopsy (LBEGFR).
Comparison: LBPA vs LBEGFR
✅ Oncomine™ Precision Assay Liquid Biopsy (LBPA)
- Mnemonic: LBPA
- Specimen: Blood (cell-free DNA, 10 mL)
- Container: Streck tube (camouflage-top glass)
- Transport: Room temperature to NRL ASAP
- Turnaround: ~10 working days
- Indications:
- Applicable to all patients with histologically confirmed malignancy
- Used to identify treatable or treatment-resistant mutations
✅ EGFR T790M Liquid Biopsy (LBEGFR)
- Mnemonic: LBEGFR
- Specimen: Blood (cell-free DNA, 10 mL)
- Container: Streck tube
- Transport: Room temperature to NRL ASAP
- Turnaround: ~10 working days
- Indications:
- Used in non-small cell lung carcinoma (NSCLC)
- Detects the EGFR T790M mutation, which is associated with resistance to treatment
Advantages of Liquid Biopsy
- Minimally invasive
- Enables monitoring of tumour evolution
- Can detect resistance mutations like EGFR T790M
- Allows repeated testing over time
- May reduce overall costs compared to tissue biopsy (no surgery, anaesthesia, hospitalisation, etc.)
- Offers insight into intra-tumour genetic heterogeneity
Additional Advantages of LBPA
- Higher sensitivity:
- EGFR mutations detectable at 0.05% frequency (vs 5% with T790M testing)
- Broad panel testing:
- Covers 50 DNA/RNA genes
- Detects additional targetable and resistance mutations
- Fusion detection (via RNA panel):
- Identifies rearrangements in:
- ALK
- ROS
- RET
- MET
- NTRK
- Identifies rearrangements in:
📌 Note: Liquid biopsy is a complementary test, not a replacement for histological diagnosis. Tissue remains the gold standard for initial diagnosis.
📧 For more information, contact the NGS Laboratory at:
ngs@ampath.co.za
✅ Let me know if you'd like this prepared for CMS entry, HTML export, or if you're ready for the next Lab Update!
Additional Resources